Novo Nordisk
NVO
#23
Rank
โ‚น33.290 T
Marketcap
โ‚น7,521
Share price
0.15%
Change (1 day)
-16.06%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

EPS for Novo Nordisk (NVO)

EPS in 2023 (TTM): โ‚น235.77

According to Novo Nordisk's latest financial reports the company's current EPS (TTM) is โ‚น245.04. In 2022 the company made an earnings per share (EPS) of โ‚น186.23 an increase over its 2021 EPS that were of โ‚น170.83.

EPS history for Novo Nordisk from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น235.7726.61%
2022โ‚น186.239.01%
2021โ‚น170.8315.08%
2020โ‚น148.4414.83%
2019โ‚น129.27-1.68%
2018โ‚น131.484.96%
2017โ‚น125.2731.08%
2016โ‚น95.57-10.33%
2015โ‚น106.5813.91%
2014โ‚น93.564.03%
2013โ‚น89.94-28.81%
2012โ‚น126.33108.9%
2011โ‚น60.4725.59%
2010โ‚น48.1535.01%
2009โ‚น35.66-9.17%
2008โ‚น39.2661.35%
2007โ‚น24.3328.96%
2006โ‚น18.8725.63%
2005โ‚น15.024.17%
2004โ‚น14.4213.55%
2003โ‚น12.7036.87%
2002โ‚น9.28-6.99%
2001โ‚น9.9821.56%
2000โ‚น8.2149.45%
1999โ‚น5.493.78%
1998โ‚น5.2912.15%
1997โ‚น4.7224.74%
1996โ‚น3.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น159.60-34.87%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น465.85 90.12%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น340.64 39.02%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น272.88 11.36%๐Ÿ‡ซ๐Ÿ‡ท France